Table 3

Comorbidities, as identified by medicine use, across clusters

ComorbidityGP managed cluster, younger n=979GP managed cluster, older n=695Psychiatrist managed cluster n=320GP physiotherapy cluster n=159GP exercise physiology cluster n=133P value
Alcohol dependence % (95% CI)0.4 (0.0 to 0.8)0.4 (0 to 0.9)4 (2 to 7)3 (0 to 6)3 (0 to 6)<0.0001
Allergies % (95% CI)3 (2 to 4)5 (4 to 7)8 (5 to 11)8 (3 to 12)10 (5 to 15)<0.0001
Anticoagulants % (95% CI)1 (0 to 1)5 (4 to 7)6 (3 to 9)4 (1 to 8)6 (2 to 10)<0.0001
Antiplatelet agents % (95% CI)1 (1 to 2)11 (9 to 14)6 (3 to 8)6 (2 to 10)13 (7 to 19)<0.0001
Arrhythmia % (95% CI)02 (1 to 3)1 (0 to 1)02 (0 to 4)<0.0001
Congestive heart failure % (95% CI)0.2 (0 to 0.5)2 (1 to 4)1 (0 to 1)05 (1 to 9)<0.0001
Diabetes % (95% CI)4 (3 to 6)13 (10 to 15)8 (5 to 11)6 (2 to 10)10 (5 to 15)<0.0001
Gastro-oesophageal reflux disorder % (95% CI)19 (17 to 22)37 (33 to 40)39 (34 to 44)30 (23 to 37)38 (29 to 46)<0.0001
Glaucoma % (95% CI)0.2 (0 to 0.5)2 (1 to 3)1 (0 to 2)1 (0 to 2)2 (0 to 5)0.001
Gout % (95% CI)2 (1 to 3)9 (7 to 11)6 (3 to 8)4 (1 to 8)9 (4 to 14)<0.0001
Hyperlipidaemia % (95% CI)12 (10 to 15)43 (40 to 47)23 (18 to 27)25 (18 to 32)41 (32 to 49)<0.0001
Hypertension % (95% CI)9 (7 to 11)36 (32 to 40)18 (13 to 22)16 (10 to 21)23 (16 to 31)<0.0001
Hypothyroidism % (95% CI)1 (0 to 2)3 (2 to 4)4 (2 to 6)1 (0 to 3)2 (0 to 4)0.013
Ischaemic heart disease-angina % (95% CI)0.2 (0 to 0.5)2 (1 to 4)1 (0 to 2)1 (0 to 3)2 (0 to 4)0.0003
Ischaemic heart disease-hypertension % (95% CI)6 (5 to 8)21 (18 to 24)11 (8 to 15)10 (5 to 15)17 (11 to 24)<0.0001
Malignancies % (95% CI)1 (0 to 1)4 (2 to 5)2 (0 to 3)03 (0 to 6)<0.0001
Migraine % (95% CI)2 (1 to 2)1 (0 to 1)2 (0 to 3)1 (0 to 3)00.280
Parkinsons % (95% CI)1 (0 to 1)1 (1 to 2)3 (1 to 5)1 (0 to 2)1 (0 to 2)0.007
Chronic airways disease % (95% CI)4 (3 to 6)10 (8 to 12)12 (9 to 16)14 (9 to 20)11 (6 to 17)<0.0001
Steroid responsive diseases % (95% CI)3 (2 to 4)6 (4 to 8)8 (5 to 11)8 (3 to 12)8 (3 to 12)<0.0001
  • GP, general practitioner.